Navigation Links
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Date:1/5/2009

lished in September 2006, provides Prism with non-dilutive capital to enable the company to bring NEXTERONE through the period of NDA review and commercial launch.

Dr. Cooper will present the corporate strategy for PRISM Pharmaceuticals, the commercial plans for NEXTERONE and the product pipeline at the 27th Annual JP Morgan Healthcare Conference on January 13, 2009 at 7:30 a.m. PST/10:30 a.m. EST. A webcast of the presentation will be available on http://www.prismpharma.com.

About Ventricular Fibrillation and Ventricular Tachycardia

Ventricular fibrillation is a condition in which the heart's electrical activity becomes disordered. When this happens, the heart's lower (pumping) chambers contract in a rapid, unsynchronized way. (The ventricles "flutter" rather than beat.) The heart pumps little or no blood. Ventricular fibrillation is very serious. Collapse and sudden cardiac death will follow in minutes unless medical help is provided immediately.

Ventricular tachycardia is a fast or rapid heart rate that starts in the heart's lower chambers (ventricles). Ventricular tachycardia may result from serious heart disease and usually requires prompt treatment.

Important Safety Information About NEXTERONE

The most important treatment-emergent adverse effects associated with intravenous amiodarone therapy in clinical studies were hypotension, asystole/cardiac arrest/electromechanical dissociation (EMD), cardiogenic shock, congestive heart failure, bradycardia, liver function test abnormalities, ventricular tachycardia, and atrioventricular block. Overall, treatment was discontinued for about 9 percent of the patients because of adverse effects. The most common adverse effects leading to discontinuation of intravenous amiodarone therapy were hypotension (1.6 percent), asystole/cardiac arrest/EMD (1.2 percent)
'/>"/>

SOURCE Prism Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
2. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
3. Prism glasses expand the view for patients with hemianopia
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...xt 25 years, the number of Americans living with d...illion in 2009 to 44.1 million in 2034. Over the s...e, rising from $113 billion to $336 billion, even ...earchers based at the University of Chicago report... number of those with diabetes covered by Medicare...
(Date:11/26/2009)...bigger thrill when on an emotional rollercoaster, ...hDay News) -- Call it the fear factor meets the ju...spectators -- especially those who root for the wi...t,s a closely contested match and victory was in d.... , Chew on that this Thanksgiving weekend as y...
(Date:11/26/2009)... Research Triangle Dental (RTDental)... Carolina, today announced the expansion of its se...R Dentist, Dr. Doug Macmillan. , ... Dental is pleased to announce that Dr. Doug Macmi... completed an additional advanced training seminar...
(Date:11/25/2009)... EDINA, Minn., Nov. 25 ...of their dentist. But a chiropractor can also giv...Temporal-Mandibular Joint, which is where your jaw...poral bone). ,, The most common symptoms assoc...clicking or popping of the jaw. But many other sy...
(Date:11/25/2009)..., TORONTO and CALGARY, Nov. 25 /PRNewswire/ - Sent...netic Resonance Imaging (MRI) coils and software a...software enabling technologies, have introduced a ...ization software. ,, This innovative interface ... medical imaging offering in the market. Calgary S...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...n Florida’s coast, a yearly occurrence, is a sign ...he ‘Red tide’ time, is undoubtedly// red alert for...ght, triggering difficulties in breathing. Researc...se. Barbara Kirkpatrick of the Mote Marine L...
...School of Medicine have found that a thyroid hormo...ein UCP2, which can maintain appetite during perio...hen food is reintroduced. Published in the J...iano, associate professor in the Departments of Ob...
... infection of drug resistant forms of HIV even whe...y Researchers at the Duke University Medical Cente...resistant viral strains even when present in small... test is expected to be of great help to doctors i...
...otting drug given to patients suffering from atria... the number of strokes due to clotting. Howe...ease in the number of strokes caused by bleeding...the nineties suggested Warfarin reduced the risk o...
...ending every waking hour in front of the computer ... in the new year is out of the window and no soone... While you recline and read this piece, the A...online fitness and nutrition tracker, to put you i...
...u think this piece of news is science fiction; now...ms with the desired characteristics- hair color, e...n advance. The Abraham Center of Life in San...eir prospective child. Though this move has brough...
Other Medicine News:Health News:Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke 2
(Date:11/25/2009)...RANCHO CORDOVA, Calif., Nov. 25 AM...ican Pacific Corporation (Nasdaq: APFC ) announce...ibility and Sustainability Award at the Annual Sta...fornia Manufacturers and Technology Association (C...A) and the Chemical Industry Council of California...
(Date:11/25/2009)...NION CITY, Calif., Nov. 25 /PRNewswire-FirstCall/ ...ts company manufacturing point-of-care blood analy...chairman and chief executive officer, will present...erence on Wednesday, December 2, 2009 at 2:00 p.m....alace Hotel in New York City. ,, About Abaxis ...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Pain Manag...nker.com/p0164220/Pain-Management---Global-Trends....gs, emergence of pain management clinics, and the ...rowth in the pain management market. Healthcare re...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Cyberonics Provides Update on Depression Post Approval Study 4778 1Cyberonics Provides Update on Depression Post Approval Study 4778 2Cyberonics Provides Update on Depression Post Approval Study 4778 3NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 1NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 2NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 3NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 4Worlds First Cardiac Adult Stem Cell Patient Receives Infusion 4776 1Worlds First Cardiac Adult Stem Cell Patient Receives Infusion 4776 2
...de Initial Proof of Concept Across Multiple ... Poster Presentation Number: 2032 ...n, MUNICH, Germany, Sept. 2 Regado Biosciences, ...sive results from Phase Ia, Ib,and Ic studies of t...ropean,Society of Cardiology,s Congress 2008, curr...
...rker and Imaging Study) Results Demonstrate ..., SAN DIEGO, Calif., Sept. 2 Volcano,Corporation... manufacturer of,intravascular ultrasound (IVUS) a...d today the use of its VH(R) IVUS (Virtual Histolo...ated Biomarker and Imaging Study). In,the study, V...
Other Medicine Technology:Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 2Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 3Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 4Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 2Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 3Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 4
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: